• Mashup Score: 0
    Close this dialog - 10 month(s) ago

    Bringing Together Relevant Partners to Advance Biomarker Identification and TestingSELECT DISEASE STATE TO EXPLORELEARN ABOUT OUR MISSIONOur MissionTo bring key stakeholders (HCPs, pharmaceutical and biotech companies, associations and advocacy groups) together for the common purpose of providing accurate and relevant information to the broader oncology community about the importance of testing…

    Source: www.onclive.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of OncLive
      OncLive

      Education plays a crucial role in #biomarker testing for #NSCLC. Discover valuable resources and learn how to effectively implement testing. Learn More https://t.co/lImehvwBsK https://t.co/HD2BJAq1A8

  • Mashup Score: 2
    DNA Methylation Urine Biomarkers Test Shows Promise in Diagnosing Upper Tract Urothelial Cancer - Angelo Territo & Andrea Gallioli - 10 month(s) ago

    Andrea Gallioli and Angelo Territo join Sam Chang in a discussion on using DNA methylation markers to diagnose upper tract urothelial carcinoma in a single center prospective clinical trial. They evaluated the accuracy of a urine biomarker test called Bladder EpiCheck and compared it with urinary cytology. EpiCheck outperformed cytology in any aspect, with a higher sensitivity and negative…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      #DNA methylation urine biomarkers test shows promise in diagnosing upper tract #UrothelialCancer - @agallioli & @AngeloTerrito join @UroCancerMD to discuss the use of urine #biomarker test Bladder #EpiCheck on UroToday > https://t.co/ZsasdWHK0O @NUCLEIX2 https://t.co/3jdhCpfcWj

  • Mashup Score: 0
    Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction - 11 month(s) ago

    Background: The tumor stroma is composed of a complex network of non-cancerous cells and extracellular matrix elements that collectively are crucial for cancer progression and treatment response. Within the realm of ovarian cancer, the expression of the stromal gene cluster has been linked to poorer progression-free and overall survival rates. However, in the age of precision medicine and genome…

    Source: bioRxiv
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of cancerassassin1
      cancerassassin1

      We’ve got a new study posted @biorxivpreprint. It’s on #ovariancancer tumor-stroma #histopathology as a #biomarker of #chemoresistance: Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction https://t.co/rWsSyOfcie #gyncsm

  • Mashup Score: 2
    Quantifying Fluid in AMD - Retina Today - 11 month(s) ago

    Central subfoveal thickness isn’t the only biomarker clinicians can use to track disease progression and treatment effect.

    Source: Retina Today
    Categories: Latest Headlines, Ophthalmology
    Tweet Tweets with this article
    • Profile photo of RetinaToday
      RetinaToday

      Quantifying Fluid in AMD: Central #subfoveal thickness isn’t the only #biomarker clinicians can use to track disease progression and treatment effect. https://t.co/7qbtFLZqRn https://t.co/zLDmxFxCdG

  • Mashup Score: 0
    DNA Methylation Urine Biomarkers Test Shows Promise in Diagnosing Upper Tract Urothelial Cancer - Angelo Territo & Andrea Gallioli - 11 month(s) ago

    Andrea Gallioli and Angelo Territo join Sam Chang in a discussion on using DNA methylation markers to diagnose upper tract urothelial carcinoma in a single center prospective clinical trial. They evaluated the accuracy of a urine biomarker test called Bladder EpiCheck and compared it with urinary cytology. EpiCheck outperformed cytology in any aspect, with a higher sensitivity and negative…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      #DNA methylation urine biomarkers test shows promise in diagnosing upper tract #UrothelialCancer - @agallioli & @AngeloTerrito join @UroCancerMD to discuss the use of urine #biomarker test Bladder #EpiCheck on UroToday > https://t.co/ZsasdWHK0O @NUCLEIX2 https://t.co/GjSJzfOZsW

  • Mashup Score: 1
    Biomarker reduction indicates treatment response to Belimumab - 12 month(s) ago

    Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in lupus nephritis. Dr Fava elucidates on the correlation betwee

    Source: SoundCloud
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of Lupus_SM
      Lupus_SM

      #Lupus #Science & #Medicine and @LupusOrg Dr. Anna Wolska interviews Dr. Andrea Fava from @JohnHopkinsUni1 about #Belimumab treatment in lupus #nephritis. #SLE #Rheumatology #EULAR2023 #LupusNephritis #Treatment #Biomarker #precisionmedicine #trials https://t.co/w4ZzAavQ8F

Load More